Interaction of SARS-CoV-2 spike protein with angiotensin converting enzyme inhibitors and selected compounds from the chemical entities of biological interest

BACKGROUND: Recent COVID-19 outbreak has prompted the search of novel therapeutic agents to treat the disease. The initial step of the infection involves the binding of the virus through the viral spike protein with the host angiotensin converting enzyme 2 (ACE2). In this study, the interaction of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Aminu, Suleiman, Ibrahim, Mohammed Auwal, Sallau, Abdullahi Balarabe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386153/
https://www.ncbi.nlm.nih.gov/pubmed/34458381
http://dx.doi.org/10.1186/s43088-021-00138-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386153/
https://www.ncbi.nlm.nih.gov/pubmed/34458381
http://dx.doi.org/10.1186/s43088-021-00138-3

Ejemplares similares